Fig. 3 | Scientific Reports

Fig. 3

From: Cytogenetic risk stratification combined with minimal residual disease status influences the therapeutic outcome and prognosis of multiple myelomas

Fig. 3

Subgroup analyses on the survival of MM patients. A, B The median PFS (A) and OS (B) in MM patients divided by the MRD status. (C, D) The median PFS (C) and OS (D) in MM patients divided by the cytogenetic risk stratification combined with the MRD status. (E, F) The median PFS (E) and OS (F) in MM patients divided by the clinical response combined with the MRD status.

Back to article page